Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ShigActive in experimental Shigella challenge
NCT05182749Phase 2Active, not recruiting
- Sponsor
- Intralytix, Inc.
- Start
- Feb 2023
- Primary completion
- Dec 2024
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of shigactive in shigellosis, sponsored by Intralytix, Inc.. Started Feb 2023; status: active, not recruiting.
02
Drugs
shigactive
03
Conditions
shigellosis
Beyond the preview
Go deeper on NCT05182749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05182749.